4/A: Structure Therapeutics CFO Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Filing (Form 4/A)
Jun Yoon, CFO of Structure Therapeutics, files an amendment to a Form 4, correcting the stock option exercise price to reflect the price of Ordinary Shares rather than American Depositary Shares (ADSs).
Summary
- Jun Yoon, the Chief Financial Officer of Structure Therapeutics Inc., filed an amended Form 4 with the SEC on March 20, 2024.
- This amendment corrects a previous filing from March 19, 2024, regarding a stock option grant.
- The correction pertains to the exercise price of the stock option, clarifying that it is based on the fair market value per Ordinary Share, not the American Depositary Shares (ADSs).
- The stock option, granted on March 15, 2024, allows Yoon to purchase 148,134 Ordinary Shares at an exercise price of $11.75 per share.
- Vesting of the shares begins on March 1, 2025, with 1/4th of the shares vesting on that date, and the remaining shares vesting in 36 equal monthly installments thereafter, contingent upon continued service.
- Each American Depositary Share (ADS) represents three Ordinary Shares of the Issuer.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't indicate any significant positive or negative developments for the company, but transparency is generally viewed favorably.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency regarding stock options granted to key personnel.
Stakeholder Impact
- The correction of the stock option details ensures accurate information for shareholders regarding executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of the earliest transaction (stock option grant) |
| 03/19/2024 | Date of original Form 4 filing |
| 03/20/2024 | Date of amended Form 4/A filing |
| 03/01/2025 | Start date for vesting of stock options |
| 03/14/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.